May 17, 2018
The health ministry’s key reimbursement panel approved on May 16 the NHI price listing of a slew of new medicines, including MSD’s cytomegalovirus (CMV) chemotherapy Prevymis (letermovir). Listing is scheduled for May 22. The Central Social Insurance Medical Council, better...read more